Funding

Researcher : Assunta Cirella

4 funding €1,047,728.00

data available since 2018

2021

Integrating 4-1BB (CD137) agonists, interleukin-12, interleukin-18 and TGFb; antagonists in synergistic combined cancer
€459,800.00
Desarrolo preclínico y translacional de una estrategia inmunoterapia intratumoral consitente en la combinacion de BO-112 STING
€126,500.00
INTERLEUKIN-8 AND NEUTROPHIL EXTRACELLULAR TRAPS AS ACTIONABLE TARGET AND BIOMARKERS FOR CANCER IMMUNOTHERAPY
€213,555.00

2018

H2020-ITN Tumor Treg Targeting
€247,873.00

The information on this page about projects and other funding data may not be exhaustive for reasons of confidentiality and intellectual and industrial property protection. If you need more complete information, please contact the institution.